SYS-CON MEDIA Authors: Jason Bloomberg, Kevin Benedict, David H Deans, RealWire News Distribution, Gilad Parann-Nissany

News Feed Item

CVS Caremark To Present At The 31st Annual J.P. Morgan Healthcare Conference

WOONSOCKET, R.I., Dec. 28, 2012 /PRNewswire/ -- CVS Caremark Corporation (NYSE: CVS) today announced that Larry Merlo, the company's president and chief executive officer, will be making a presentation to investors at the J.P. Morgan Healthcare Conference on January 9, 2013.  Mr. Merlo is scheduled to present at 9:30 a.m. local time (12:30 p.m. ET).

(Logo:  http://photos.prnewswire.com/prnh/20090226/NE75914LOGO )

An audio webcast of the presentation will be broadcast simultaneously through the Investor Relations portion of the CVS Caremark website for all interested parties. To access the webcast, visit http://info.cvscaremark.com/investors. This webcast will be archived and available on the website for a one-year period following the presentation.

About CVS Caremark

CVS Caremark is dedicated to helping people on their path to better health as the largest integrated pharmacy company in the United States. Through the company's more than 7,400 CVS/pharmacy stores; its leading pharmacy benefit manager serving more than 60 million plan members; and its retail health clinic system, the largest in the nation with more than 600 MinuteClinic locations, it is a market leader in mail order, retail and specialty pharmacy, retail clinics, and Medicare Part D Prescription Drug Plans.  As a pharmacy innovation company with an unmatched breadth of capabilities, CVS Caremark continually strives to improve health and lower costs by developing new approaches such as its unique Pharmacy Advisor program that helps people with chronic diseases, such as diabetes, obtain and stay on their medications.  Find more information about how CVS Caremark is reinventing pharmacy for better health at info.cvscaremark.com.

 

SOURCE CVS Caremark Corporation

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.